↓ Skip to main content

Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial

Overview of attention for article published in Lancet Infectious Diseases, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Citations

dimensions_citation
185 Dimensions

Readers on

mendeley
221 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial
Published in
Lancet Infectious Diseases, December 2012
DOI 10.1016/s1473-3099(12)70300-6
Pubmed ID
Authors

Paul Little, Beth Stuart, Michael Moore, Samuel Coenen, Christopher C Butler, Maciek Godycki-Cwirko, Artur Mierzecki, Slawomir Chlabicz, Antoni Torres, Jordi Almirall, Mel Davies, Tom Schaberg, Sigvard Mölstad, Francesco Blasi, An De Sutter, Janko Kersnik, Helena Hupkova, Pia Touboul, Kerenza Hood, Mark Mullee, Gilly O'Reilly, Curt Brugman, Herman Goossens, Theo Verheij, on behalf of the GRACE consortium

X Demographics

X Demographics

The data shown below were collected from the profiles of 221 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Chile 1 <1%
Korea, Republic of 1 <1%
Ireland 1 <1%
Kenya 1 <1%
Brazil 1 <1%
Slovenia 1 <1%
Belgium 1 <1%
Denmark 1 <1%
Other 4 2%
Unknown 208 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 38 17%
Other 25 11%
Student > Master 22 10%
Student > Ph. D. Student 20 9%
Student > Bachelor 19 9%
Other 59 27%
Unknown 38 17%
Readers by discipline Count As %
Medicine and Dentistry 107 48%
Pharmacology, Toxicology and Pharmaceutical Science 14 6%
Nursing and Health Professions 9 4%
Agricultural and Biological Sciences 9 4%
Immunology and Microbiology 8 4%
Other 20 9%
Unknown 54 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 218. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2024.
All research outputs
#180,330
of 25,754,670 outputs
Outputs from Lancet Infectious Diseases
#436
of 6,097 outputs
Outputs of similar age
#1,086
of 290,370 outputs
Outputs of similar age from Lancet Infectious Diseases
#3
of 92 outputs
Altmetric has tracked 25,754,670 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,097 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 92.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,370 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.